UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000008539 |
|---|---|
| Receipt number | R000009645 |
| Scientific Title | Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia |
| Date of disclosure of the study information | 2012/07/26 |
| Last modified on | 2021/05/07 10:15:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia
Acronym
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia
Scientific Title
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia
Scientific Title:Acronym
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia
Region
| Japan |
Condition
Condition
Hypertension and dyslipidemia
Classification by specialty
| Medicine in general | Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Blood pressure and LDL-Cholesterol
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Intervention by Drug combination therapy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients during current therapy with antihypertensive agent`amlodipine` and lipid-lowering agent`statin` tehrapy are eligible.
Key exclusion criteria
Patients without written imformed consent
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ryuutaro Yamaguchi |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Division of Cardiology
Zip code
Address
1981 Kamoda, Kawagoe, Saitama
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Division of Cardiology
Zip code
Address
TEL
049-228-3587
Homepage URL
Sponsor or person
Institute
Saitama Medical Center, Saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
Saitama Medical Center, Saitama Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 07 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2012 | Year | 07 | Month | 05 | Day |
Date of IRB
| 2012 | Year | 07 | Month | 05 | Day |
Anticipated trial start date
| 2012 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2012 | Year | 08 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2012 | Year | 07 | Month | 26 | Day |
Last modified on
| 2021 | Year | 05 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009645
